News & Announcements

How do you turn an interesting antibody response into an assay that works beyond the discovery platform? Two Biotome webinars, hosted by our long-standing partner PEPperPRINT and now available on YouTube, explore that journey from different starting points. CEO Dr Samuel Lundin shares the development of Helitope, our peptide-based anti-CagA IgG ELISA. CTO Luke Marshall takes a step further back, showing how our team approaches biomarker discovery when the target antigen is no

This study employed peptide microarray technology (Carmona 2015) to identify highly specific linear B-cell epitopes of the SARS-CoV-2 Spike protein that can distinguish between SARS-CoV-2 infection and pre-existing immunity to seasonal coronaviruses.

Introduction / Background Preeclampsia is a serious pregnancy complication characterised by high blood pressure and signs of organ stress that develops after 20 weeks of pregnancy. Affecting 2-8% of pregnancies worldwide, it remains a leading cause of preventable maternal and infant deaths. The disease appears in two forms with different underlying causes: early-onset disease linked to placental problems, and late-onset disease connected to maternal health conditions. Both ty

Introduction / Background Gastric (stomach) cancer ranks as the fifth most common cancer worldwide and the third leading cause of cancer-related mortality. The disease is characterised by late-stage diagnosis and poor overall survival, with five-year survival rates below 35% in most populations. Most gastric cancers are adenocarcinomas that develop following years of chronic inflammation and progressive premalignant changes. Early identification of high-risk individuals and i